Making Insulin Affordable for All

Produce three insulins in vial and pen form – glargine (Lantus), lispro (Humalog) and aspart (Novolog)

Civica insulins to be sold at one low, transparent price for all

No more than $30 per vial and no more than $55 for a box of five prefilled pens

Working to file for FDA approval for the first insulins in 2024

Initiative Partners